That's important, because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (last year). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a development practically nobody noticed. But it's going to have profound implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (black sea). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe significantly prior to going higher - last week. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. But that's not the huge question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. democratic republic. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so lots of terrific personal companies on the verge of striking the public markets And I've been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to schedule your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our usual beat (future report review). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing professionals we understand (jeff brown investor prediction). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing rapid growth and creating unbelievable chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown. However regardless of what lots of readers might think, this is a pattern that's just getting going. Even though the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown prediction). Losing 2 months of production and sales really affects how numerous 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million units is remarkable. More importantly, the delays triggered by the pandemic developed a heap of suppressed need. Which demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown top stock pick 2021. And that's not my only 5G prediction When I have actually discussed 5G in the past, I've described its three various stages.
In Phase Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services begin to be offered (genetic sequencing companies jeff brown). That's when we begin to see applications running on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summer. This begins something of a virtuous cycle: Many people do not actually appreciate the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be huge. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For several years, CRISPR was primarily a niche innovation that wasn't well comprehended. And throughout that time, there were really just 3 business operating in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire market is successfully a greenfield chance.
There's space for lots of business to exist in this space. longtime readers. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software application can properly forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is necessary since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental process. Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're developed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this innovation. This was among those breakthroughs that almost nobody noticed. However it's going to have profound implications for curing disease. And, naturally, there will be lots of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back maybe significantly prior to going higher. I've been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin - jeff brown biotech pick. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff brown 1 biotech. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date since February 2021, but we could not individually confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional perspective on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a lot of his finest choices in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively anticipated a few of the greatest financial occasions of the past twenty years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right every time, however Jeff Brown's accurate predictions have actually made him legions of devoted followers. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research study uses numerous research study services with a variety of expertises - jeff brown genome sequencing stock.
The business is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown stock predictions. On its website, Brownstone says its objective is to offer retail financiers with professional-grade research study: "For too long, the best investment research study has not been available to specific financiers. It has actually been typically booked for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown biotech stock. The objective of Brownstone Research study is to make that type of proprietary research offered to any investors seeking to gain an edge in the markets. The goal is basic to provide unique and successful financial investment research study discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you know even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown 2021 stock predictions. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown thinks S.A.V. self-driving cars. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two advanced technologies: synthetic intelligence and electrical vehicles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile market's Holy Grail. As you understand, electric lorries and self-driving cars and truck stocks have actually been big this year, however the Wall Street maker has actually approved buzz without much tangible result. Regardless of a drastic boost in competition over the previous couple of years, Brown still believes Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Generally, this technology would allow you to lease your vehicle as an autonomous, self-driving taxi when you're not using it. You just leave the vehicle and press a button on an app that tells the automobile to "join the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a large portion of the profits. It sounds ridiculous, but it might be closed than you think.